Table 1.

Demographic and inflammatory parameters of the study cohort

	Non-IBD control	Anti-TNF	Corticoid	p-value
Donors	31	31	16
Sex [F/M]	24/7	20/11	12/4
Age [years] [range]	35 [19–65]	38 [19–58]	39 [20–65]
CDAI	N/A	14–1088	37–549
Calprotectin [µg/g]	105.10 ± 15.87	685.21 ± 111.81	707.03 ± 158.66	<0.0001****
sCD14 [ng/mL]	1353.26 ± 85.73	1155.66 ± 129.31	1158.60 ± 147.90

IBD, inflammatory bowel disease; TNF, tumour necrosis factor; CDAI, Crohn’s Disease Activity Index. The analyses used to test for statistically significant differences are described in the Methods section. A p-value less than 0.05 was considered statistically significant; p-values ≥0.05 are not shown. ****ANOVA with multiple comparisons was used to determine statistical significance for calprotectin levels, p < 0.0001.